Cadia Private Client’s Halozyme HALO Stock Holding History

Cadia Private Client’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Hold	21,500	–	–	1.21%	19
2026 Q1	$1.39M	Hold	21,500	–	–	1.13%	18
2025 Q4	$1.45M	Buy	+21,500	New	+$1.45M	1.15%	18

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Cadia Private Client's HALO Position: Q2 2026 in Review

Cadia Private Client held its Halozyme (HALO) position steady in Q2 2026 at 21,500 shares worth $1.68M. The position accounts for 1.21% of the portfolio, ranked #19.

Cadia Private Client first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Cadia Private Client held 21,500 shares of Halozyme worth $1.68M as of Q2 2026.
Cadia Private Client left its Halozyme share count unchanged in Q2 2026.
Halozyme made up 1.21% of Cadia Private Client's portfolio in Q2 2026, its #19 holding.
Cadia Private Client first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Cadia Private Client's 13F filing for Q2 2026, filed 11 Aug 2026.